Correlation Between Kiora Pharmaceuticals and Sonnet Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Sonnet Biotherapeutics.

Diversification Opportunities for Kiora Pharmaceuticals and Sonnet Biotherapeutics

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Kiora and Sonnet is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Kiora Pharmaceuticals and Sonnet Biotherapeutics

Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 0.74 times more return on investment than Sonnet Biotherapeutics. However, Kiora Pharmaceuticals is 1.36 times less risky than Sonnet Biotherapeutics. It trades about -0.04 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.58 per unit of risk. If you would invest  349.00  in Kiora Pharmaceuticals on August 23, 2024 and sell it today you would lose (18.00) from holding Kiora Pharmaceuticals or give up 5.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kiora Pharmaceuticals  vs.  Sonnet Biotherapeutics Holding

 Performance 
       Timeline  
Kiora Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Sonnet Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Kiora Pharmaceuticals and Sonnet Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kiora Pharmaceuticals and Sonnet Biotherapeutics

The main advantage of trading using opposite Kiora Pharmaceuticals and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.
The idea behind Kiora Pharmaceuticals and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Correlations
Find global opportunities by holding instruments from different markets